{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:16:25Z","timestamp":1762870585997,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"am","delay-in-days":425,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jdmv.2021.08.001","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T08:43:00Z","timestamp":1629794580000},"page":"215-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient education program at the forefront of cancer-associated thrombosis care"],"prefix":"10.1016","volume":"46","author":[{"given":"M.","family":"Sebuhyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Crichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Deville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Le Maignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Marjanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Bensaoula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ndour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Frere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Madeleine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Farge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdmv.2021.08.001_bib0150","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0155","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0160","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0165","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(19)31674-5","article-title":"Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases","volume":"394","author":"Strongman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0170","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.critrevonc.2008.12.004","article-title":"2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working group","volume":"73","author":"Farge","year":"2010","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0180","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/annonc\/mdp052","article-title":"2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group","volume":"20","author":"Debourdeau","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0185","first-page":"6S24","article-title":"How to treat venous thromboembolism (TVE) in cancer patients: ten years of multidisciplinary team meetings (MDTM) at Saint-Louis Hospital","volume":"45","author":"Crichi","year":"2020","journal-title":"J Med Vasc"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0190","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/annonc\/mdp167","article-title":"Management of venous thromboembolism in cancer patients: ESMO clinical recommendations","volume":"20","author":"Mandal\u00e0","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0195","doi-asserted-by":"crossref","first-page":"vi85","DOI":"10.1093\/annonc\/mdr392","article-title":"Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines","volume":"22","author":"Mandal\u00e0","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0200","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th Edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0205","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0210","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1200\/JCO.2013.49.1118","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology clinical practice guideline update","volume":"31","author":"Lyman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jth.12070","article-title":"International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"11","author":"Farge","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0220","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jth.12071","article-title":"International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer","volume":"11","author":"Debourdeau","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0225","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S1470-2045(16)30369-2","article-title":"International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"17","author":"Farge","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0230","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1016\/S1470-2045(19)30336-5","article-title":"2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"20","author":"Farge","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0235","doi-asserted-by":"crossref","first-page":"E71","DOI":"10.3390\/cancers11010071","article-title":"Recent advances in the management of cancer-associated thrombosis: new hopes but new challenges","volume":"11","author":"Frere","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0002-9343(97)00467-1","article-title":"Compliance with treatment regimens in chronic asymptomatic diseases","volume":"102","author":"Miller","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0245","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2125.2006.02806.x","article-title":"Warfarin: almost 60 years old and still causing problems","volume":"62","author":"Pirmohamed","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0250","article-title":"Effectiveness of a multidisciplinary care program for the management of venous thromboembolism in cancer patients: a pilot study","author":"Benzidia","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0255","first-page":"28","article-title":"Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe francophone thrombose et cancer (GFTC)","volume":"45","author":"Rafii","year":"2020","journal-title":"J Med Vasc"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0260","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.amjcard.2020.07.027","article-title":"Meta-analysis comparing direct oral anticoagulants to low molecular weight heparin for treatment of venous thromboembolism in patients with cancer","volume":"133","author":"Bhatia","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jmv.2014.03.001","article-title":"Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study","volume":"39","author":"Sevestre","year":"2014","journal-title":"J Mal Vasc"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0270","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/PPA.S79373","article-title":"Patients\u2019 experiences of LIving with CANcer-associated thrombosis: the PELICAN study","volume":"9","author":"Noble","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0275","first-page":"3233","article-title":"Patients\u2019 Experience of Living with Cancer-associated thrombosis in Spain (PELICANOS)","volume":"26","author":"Font","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0280","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.thromres.2020.06.024","article-title":"Patients experience of living with cancer associated thrombosis in France (Le PELICAN)","volume":"194","author":"Mah\u00e9","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0285","first-page":"375","article-title":"New international guidelines for curative treatment and prophylaxis for venous thromboembolism (VTE) in cancer patients and the dedicated smartphone application","volume":"42","author":"Benzidia","year":"2017","journal-title":"J Med Vasc"},{"key":"10.1016\/j.jdmv.2021.08.001_bib0290","article-title":"Development of a multi-language mobile app to implement the 2019 ITAC clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in cancer patients","volume":"5","author":"Farge","year":"2021","journal-title":"Res Pract Thromb Haemost"}],"container-title":["JMV-Journal de M\u00e9decine Vasculaire"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S254245132100105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S254245132100105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:06:00Z","timestamp":1762869960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S254245132100105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":29,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S254245132100105X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdmv.2021.08.001","relation":{},"ISSN":["2542-4513"],"issn-type":[{"type":"print","value":"2542-4513"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient education program at the forefront of cancer-associated thrombosis care","name":"articletitle","label":"Article Title"},{"value":"JMV-Journal de M\u00e9decine Vasculaire","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdmv.2021.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}